241 related articles for article (PubMed ID: 9663430)
21. Semiquantitative immunoblot analysis of nm23-H1 and -H2 isoforms in adenocarcinomas of the lung: prognostic significance.
Sato Y; Tsuchiya B; Urao T; Baba H; Shiku H; Kodama T; Kameya T
Pathol Int; 2000 Mar; 50(3):200-5. PubMed ID: 10792783
[TBL] [Abstract][Full Text] [Related]
22. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
Heimann R; Lan F; McBride R; Hellman S
Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases.
Lai WW; Wu MH; Yan JJ; Chen FF
Ann Thorac Surg; 1996 Nov; 62(5):1500-4. PubMed ID: 8893591
[TBL] [Abstract][Full Text] [Related]
24. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
[TBL] [Abstract][Full Text] [Related]
25. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
26. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma.
Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Honma Y; Higashihara M; Okabe-Kado J; Hirano M;
Br J Haematol; 2003 Nov; 123(4):621-30. PubMed ID: 14616965
[TBL] [Abstract][Full Text] [Related]
27. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical evaluation of nm23-H1 gene product in transitional cell carcinoma of the bladder.
Nakopoulou LL; Constandinides CA; Tzonou A; Lazaris AC; Zervas A; Dimopoulos CA
Histopathology; 1996 May; 28(5):429-35. PubMed ID: 8735718
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical analysis of the nm23 gene products in testicular seminoma.
Hori K; Uematsu K; Yasoshima H; Sakurai K; Yamada A; Ohya M
Pathol Int; 1997 May; 47(5):288-92. PubMed ID: 9143023
[TBL] [Abstract][Full Text] [Related]
30. NM23-H1 and NM23-H2 gene expression in human renal tumors.
Theisinger B; Engel M; Seifert M; Seitz G; Welter C
Anticancer Res; 1998; 18(2A):1185-9. PubMed ID: 9615786
[TBL] [Abstract][Full Text] [Related]
31. nm23 in the primary and metastatic sites of gastric carcinoma. Relation to AFP-producing carcinoma.
Kumar Dhar D; Kubota H; Tabara H; Kotoh T; Monden N; Igarashi M; Kohno H; Nagasue N
Oncology; 1999; 56(2):122-8. PubMed ID: 9949298
[TBL] [Abstract][Full Text] [Related]
32. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages.
Martinez JA; Prevot S; Nordlinger B; Nguyen TM; Lacarriere Y; Munier A; Lascu I; Vaillant JC; Capeau J; Lacombe ML
Gut; 1995 Nov; 37(5):712-20. PubMed ID: 8549951
[TBL] [Abstract][Full Text] [Related]
34. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.
Tannapfel A; Katalinic A; Köckerling F; Wittekind C
Am J Gastroenterol; 1997 Jul; 92(7):1182-6. PubMed ID: 9219795
[TBL] [Abstract][Full Text] [Related]
35. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.
Mandai M; Konishi I; Koshiyama M; Komatsu T; Yamamoto S; Nanbu K; Mori T; Fukumoto M
Cancer; 1995 May; 75(10):2523-9. PubMed ID: 7736397
[TBL] [Abstract][Full Text] [Related]
36. The NM23 gene and its expression in oral squamous cell carcinoma.
Lo Muzio L; Mignogna MD; Pannone G; Staibano S; Procaccini M; Serpico R; De Rosa G; Scully C
Oncol Rep; 1999; 6(4):747-51. PubMed ID: 10373649
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.
Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Horschowski N; Lavaut MN; Allasia C
J Pathol; 1998 Apr; 184(4):401-7. PubMed ID: 9664906
[TBL] [Abstract][Full Text] [Related]
38. NM23 expression as prognostic factor in colorectal carcinoma.
Forte A; D'Urso A; Gallinaro LS; Lo Storto G; Soda G; Bosco D; Bezzi M; Vietri F; Beltrami V
G Chir; 2002 Mar; 23(3):61-3. PubMed ID: 12109225
[TBL] [Abstract][Full Text] [Related]
39. The role of nm23-H1 in the progression of transitional cell bladder cancer.
Chow NH; Liu HS; Chan SH
Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
[TBL] [Abstract][Full Text] [Related]
40. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.
Iizuka N; Oka M; Noma T; Nakazawa A; Hirose K; Suzuki T
Cancer Res; 1995 Feb; 55(3):652-7. PubMed ID: 7530600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
